Development of an individualized dementia risk prediction model using deep learning survival analysis incorporating genetic and environmental factors
Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or treatment are of significant clinical importance. Neural network survival analysis represents the most advanced technology for survival analysis to date. However,...
Saved in:
Published in | Alzheimer's research & therapy Vol. 16; no. 1; pp. 278 - 17 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
30.12.2024
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or treatment are of significant clinical importance. Neural network survival analysis represents the most advanced technology for survival analysis to date. However, there is a lack of deep learning-based survival analysis models that integrate both genetic and clinical factors to develop and validate individualized dynamic dementia risk prediction models.
This study is based on a large prospective cohort from the UK Biobank, which includes a total of 41,484 participants with an average follow-up period of 12.6 years. Initially, 364 candidate features (predictor variables) were screened. The top 30 key features were then identified by ranking the importance of each predictor variable using the Gradient Boosting Machine (GBM) model. A multi-model comparison strategy was employed to evaluate the predictive performance of four survival analysis models: DeepSurv, DeepHit, Kaplan-Meier estimation, and the Cox proportional hazards model (CoxPH). The results showed that the average Harrell's C-index for the DeepSurv model was 0.743, for the DeepHit model it was 0.633, for the CoxPH model it was 0.749, and for the Kaplan-Meier estimator model it was 0.500. In addition, the average D-Calibration Survival Measure was 6.014, 4408.086, 32274.743, and 1.508, respectively. The Brier score (BS) was used to assess the importance of features for the DeepSurv dementia prediction model, and the relationship between features and dementia was visualized using a partial dependence plot (PDP). To facilitate further research, the team deployed the DeepSurv dementia prediction model on AliCloud servers and designated it as the UKB-DementiaPre Tool.
This study successfully developed and validated the DeepSurv dementia prediction model for individuals aged 60 years and above, integrating both genetic and clinical data. The model was then deployed on AliCloud servers to promote its clinical translation. It is anticipated that this prediction model will provide more accurate decision support for clinical treatment and will serve as a valuable tool for the primary prevention of dementia. |
---|---|
AbstractList | Background Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or treatment are of significant clinical importance. Neural network survival analysis represents the most advanced technology for survival analysis to date. However, there is a lack of deep learning-based survival analysis models that integrate both genetic and clinical factors to develop and validate individualized dynamic dementia risk prediction models. Methods and results This study is based on a large prospective cohort from the UK Biobank, which includes a total of 41,484 participants with an average follow-up period of 12.6 years. Initially, 364 candidate features (predictor variables) were screened. The top 30 key features were then identified by ranking the importance of each predictor variable using the Gradient Boosting Machine (GBM) model. A multi-model comparison strategy was employed to evaluate the predictive performance of four survival analysis models: DeepSurv, DeepHit, Kaplan-Meier estimation, and the Cox proportional hazards model (CoxPH). The results showed that the average Harrell's C-index for the DeepSurv model was 0.743, for the DeepHit model it was 0.633, for the CoxPH model it was 0.749, and for the Kaplan-Meier estimator model it was 0.500. In addition, the average D-Calibration Survival Measure was 6.014, 4408.086, 32274.743, and 1.508, respectively. The Brier score (BS) was used to assess the importance of features for the DeepSurv dementia prediction model, and the relationship between features and dementia was visualized using a partial dependence plot (PDP). To facilitate further research, the team deployed the DeepSurv dementia prediction model on AliCloud servers and designated it as the UKB-DementiaPre Tool. Conclusion This study successfully developed and validated the DeepSurv dementia prediction model for individuals aged 60 years and above, integrating both genetic and clinical data. The model was then deployed on AliCloud servers to promote its clinical translation. It is anticipated that this prediction model will provide more accurate decision support for clinical treatment and will serve as a valuable tool for the primary prevention of dementia. Keywords: Dementia, DeepSurv, Risk prediction model, Survival analysis Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or treatment are of significant clinical importance. Neural network survival analysis represents the most advanced technology for survival analysis to date. However, there is a lack of deep learning-based survival analysis models that integrate both genetic and clinical factors to develop and validate individualized dynamic dementia risk prediction models. This study is based on a large prospective cohort from the UK Biobank, which includes a total of 41,484 participants with an average follow-up period of 12.6 years. Initially, 364 candidate features (predictor variables) were screened. The top 30 key features were then identified by ranking the importance of each predictor variable using the Gradient Boosting Machine (GBM) model. A multi-model comparison strategy was employed to evaluate the predictive performance of four survival analysis models: DeepSurv, DeepHit, Kaplan-Meier estimation, and the Cox proportional hazards model (CoxPH). The results showed that the average Harrell's C-index for the DeepSurv model was 0.743, for the DeepHit model it was 0.633, for the CoxPH model it was 0.749, and for the Kaplan-Meier estimator model it was 0.500. In addition, the average D-Calibration Survival Measure was 6.014, 4408.086, 32274.743, and 1.508, respectively. The Brier score (BS) was used to assess the importance of features for the DeepSurv dementia prediction model, and the relationship between features and dementia was visualized using a partial dependence plot (PDP). To facilitate further research, the team deployed the DeepSurv dementia prediction model on AliCloud servers and designated it as the UKB-DementiaPre Tool. This study successfully developed and validated the DeepSurv dementia prediction model for individuals aged 60 years and above, integrating both genetic and clinical data. The model was then deployed on AliCloud servers to promote its clinical translation. It is anticipated that this prediction model will provide more accurate decision support for clinical treatment and will serve as a valuable tool for the primary prevention of dementia. Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or treatment are of significant clinical importance. Neural network survival analysis represents the most advanced technology for survival analysis to date. However, there is a lack of deep learning-based survival analysis models that integrate both genetic and clinical factors to develop and validate individualized dynamic dementia risk prediction models.BACKGROUNDDementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or treatment are of significant clinical importance. Neural network survival analysis represents the most advanced technology for survival analysis to date. However, there is a lack of deep learning-based survival analysis models that integrate both genetic and clinical factors to develop and validate individualized dynamic dementia risk prediction models.This study is based on a large prospective cohort from the UK Biobank, which includes a total of 41,484 participants with an average follow-up period of 12.6 years. Initially, 364 candidate features (predictor variables) were screened. The top 30 key features were then identified by ranking the importance of each predictor variable using the Gradient Boosting Machine (GBM) model. A multi-model comparison strategy was employed to evaluate the predictive performance of four survival analysis models: DeepSurv, DeepHit, Kaplan-Meier estimation, and the Cox proportional hazards model (CoxPH). The results showed that the average Harrell's C-index for the DeepSurv model was 0.743, for the DeepHit model it was 0.633, for the CoxPH model it was 0.749, and for the Kaplan-Meier estimator model it was 0.500. In addition, the average D-Calibration Survival Measure was 6.014, 4408.086, 32274.743, and 1.508, respectively. The Brier score (BS) was used to assess the importance of features for the DeepSurv dementia prediction model, and the relationship between features and dementia was visualized using a partial dependence plot (PDP). To facilitate further research, the team deployed the DeepSurv dementia prediction model on AliCloud servers and designated it as the UKB-DementiaPre Tool.METHODS AND RESULTSThis study is based on a large prospective cohort from the UK Biobank, which includes a total of 41,484 participants with an average follow-up period of 12.6 years. Initially, 364 candidate features (predictor variables) were screened. The top 30 key features were then identified by ranking the importance of each predictor variable using the Gradient Boosting Machine (GBM) model. A multi-model comparison strategy was employed to evaluate the predictive performance of four survival analysis models: DeepSurv, DeepHit, Kaplan-Meier estimation, and the Cox proportional hazards model (CoxPH). The results showed that the average Harrell's C-index for the DeepSurv model was 0.743, for the DeepHit model it was 0.633, for the CoxPH model it was 0.749, and for the Kaplan-Meier estimator model it was 0.500. In addition, the average D-Calibration Survival Measure was 6.014, 4408.086, 32274.743, and 1.508, respectively. The Brier score (BS) was used to assess the importance of features for the DeepSurv dementia prediction model, and the relationship between features and dementia was visualized using a partial dependence plot (PDP). To facilitate further research, the team deployed the DeepSurv dementia prediction model on AliCloud servers and designated it as the UKB-DementiaPre Tool.This study successfully developed and validated the DeepSurv dementia prediction model for individuals aged 60 years and above, integrating both genetic and clinical data. The model was then deployed on AliCloud servers to promote its clinical translation. It is anticipated that this prediction model will provide more accurate decision support for clinical treatment and will serve as a valuable tool for the primary prevention of dementia.CONCLUSIONThis study successfully developed and validated the DeepSurv dementia prediction model for individuals aged 60 years and above, integrating both genetic and clinical data. The model was then deployed on AliCloud servers to promote its clinical translation. It is anticipated that this prediction model will provide more accurate decision support for clinical treatment and will serve as a valuable tool for the primary prevention of dementia. Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or treatment are of significant clinical importance. Neural network survival analysis represents the most advanced technology for survival analysis to date. However, there is a lack of deep learning-based survival analysis models that integrate both genetic and clinical factors to develop and validate individualized dynamic dementia risk prediction models. This study is based on a large prospective cohort from the UK Biobank, which includes a total of 41,484 participants with an average follow-up period of 12.6 years. Initially, 364 candidate features (predictor variables) were screened. The top 30 key features were then identified by ranking the importance of each predictor variable using the Gradient Boosting Machine (GBM) model. A multi-model comparison strategy was employed to evaluate the predictive performance of four survival analysis models: DeepSurv, DeepHit, Kaplan-Meier estimation, and the Cox proportional hazards model (CoxPH). The results showed that the average Harrell's C-index for the DeepSurv model was 0.743, for the DeepHit model it was 0.633, for the CoxPH model it was 0.749, and for the Kaplan-Meier estimator model it was 0.500. In addition, the average D-Calibration Survival Measure was 6.014, 4408.086, 32274.743, and 1.508, respectively. The Brier score (BS) was used to assess the importance of features for the DeepSurv dementia prediction model, and the relationship between features and dementia was visualized using a partial dependence plot (PDP). To facilitate further research, the team deployed the DeepSurv dementia prediction model on AliCloud servers and designated it as the UKB-DementiaPre Tool. This study successfully developed and validated the DeepSurv dementia prediction model for individuals aged 60 years and above, integrating both genetic and clinical data. The model was then deployed on AliCloud servers to promote its clinical translation. It is anticipated that this prediction model will provide more accurate decision support for clinical treatment and will serve as a valuable tool for the primary prevention of dementia. Abstract Background Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or treatment are of significant clinical importance. Neural network survival analysis represents the most advanced technology for survival analysis to date. However, there is a lack of deep learning-based survival analysis models that integrate both genetic and clinical factors to develop and validate individualized dynamic dementia risk prediction models. Methods and results This study is based on a large prospective cohort from the UK Biobank, which includes a total of 41,484 participants with an average follow-up period of 12.6 years. Initially, 364 candidate features (predictor variables) were screened. The top 30 key features were then identified by ranking the importance of each predictor variable using the Gradient Boosting Machine (GBM) model. A multi-model comparison strategy was employed to evaluate the predictive performance of four survival analysis models: DeepSurv, DeepHit, Kaplan–Meier estimation, and the Cox proportional hazards model (CoxPH). The results showed that the average Harrell's C-index for the DeepSurv model was 0.743, for the DeepHit model it was 0.633, for the CoxPH model it was 0.749, and for the Kaplan–Meier estimator model it was 0.500. In addition, the average D-Calibration Survival Measure was 6.014, 4408.086, 32274.743, and 1.508, respectively. The Brier score (BS) was used to assess the importance of features for the DeepSurv dementia prediction model, and the relationship between features and dementia was visualized using a partial dependence plot (PDP). To facilitate further research, the team deployed the DeepSurv dementia prediction model on AliCloud servers and designated it as the UKB-DementiaPre Tool. Conclusion This study successfully developed and validated the DeepSurv dementia prediction model for individuals aged 60 years and above, integrating both genetic and clinical data. The model was then deployed on AliCloud servers to promote its clinical translation. It is anticipated that this prediction model will provide more accurate decision support for clinical treatment and will serve as a valuable tool for the primary prevention of dementia. |
ArticleNumber | 278 |
Audience | Academic |
Author | Yang, Juying Lyu, Jun Bai, Zihong Le, Huan Ye, Qingqing Ling, Yitong Huang, Xiaxuan Yu, Juan Tan, Shanyuan Lei, Fazhen Liu, Qing Peng, Xiaoxue Yuan, Shiqi |
Author_xml | – sequence: 1 givenname: Shiqi surname: Yuan fullname: Yuan, Shiqi – sequence: 2 givenname: Qing surname: Liu fullname: Liu, Qing – sequence: 3 givenname: Xiaxuan surname: Huang fullname: Huang, Xiaxuan – sequence: 4 givenname: Shanyuan surname: Tan fullname: Tan, Shanyuan – sequence: 5 givenname: Zihong surname: Bai fullname: Bai, Zihong – sequence: 6 givenname: Juan surname: Yu fullname: Yu, Juan – sequence: 7 givenname: Fazhen surname: Lei fullname: Lei, Fazhen – sequence: 8 givenname: Huan surname: Le fullname: Le, Huan – sequence: 9 givenname: Qingqing surname: Ye fullname: Ye, Qingqing – sequence: 10 givenname: Xiaoxue surname: Peng fullname: Peng, Xiaoxue – sequence: 11 givenname: Juying surname: Yang fullname: Yang, Juying – sequence: 12 givenname: Yitong surname: Ling fullname: Ling, Yitong – sequence: 13 givenname: Jun surname: Lyu fullname: Lyu, Jun |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39736679$$D View this record in MEDLINE/PubMed |
BookMark | eNptkk1r3DAQhk1JaZJt_0APxVAIvTi1JFuWTyWkX4FAL-1ZjKXxrlKt5Eq2Q_o_8n8jZ9OwC0UHfcwzrzSa9zQ7ct5hlr0l5Tkhgn-MhJG2LkpaFSXhnBW3L7IT0tSiaEnLjvbWx9lpjDdlyTkV1avsmLUN47xpT7L7zzij9cMW3Zj7PgeXG6fNbPQE1vxFnWtcYgbyYOLvfAiojRqNd_nWa7T5FI1bJwiH3CIEt-ziFGYzg01qYO-iiUlT-TD4AOMSX6PD0agU1jm62QTvljtSQg9q9CG-zl72YCO-eZpX2a-vX35efi-uf3y7ury4LlRNxFj0VFBVdYR3PXQk7VrBuUKEWre8I7oFwJojUZS1AgWrFAOkRKhGkJ5rYKvsaqerPdzIIZgthDvpwcjHAx_WEkJ6qUWpG94AUVq0jFYa644giIbSkgreNxVNWp92WsPUbVGrVFAAeyB6GHFmI9d-loRwURFaJYUPTwrB_5kwjnJrokJrwaGfomSkLllVUcIS-n6HriG9zbjeJ0m14PJCpArTT6S2r7Lz_1BppJ4alczUm3R-kHC2l7BBsOMmejst_Y6H4Lv9Yp-r_GesBNAdoIKPMWD_jJBSLu6VO_fK5F756F55yx4AAiHloQ |
Cites_doi | 10.1371/journal.pmed.1001779 10.1371/journal.pone.0211957 10.1371/journal.pone.0251365 10.3390/bs13090737 10.1001/jamainternmed.2016.6807 10.1093/hmg/ddz187 10.3389/fpsyg.2024.1410396 10.1038/s41598-023-27892-x 10.3390/bioengineering10020245 10.1186/s12890-024-02945-7 10.1016/S1474-4422(15)00092-7 10.1093/cvr/cvz294 10.1093/ageing/afx044 10.1186/s12916-016-0549-y 10.1186/s12874-018-0482-1 10.1186/s12859-020-03850-6 10.1136/bmjopen-2015-008048 10.1161/CIRCRESAHA.122.319951 10.1038/s41582-022-00698-7 10.3390/s23187712 10.1038/s41598-020-60444-1 10.1007/s11892-014-0487-z 10.1177/2040622321992624 10.2337/dc15-1588 10.3389/fpls.2021.749854 10.3390/diagnostics13193159 10.1186/s12916-020-01578-x 10.1177/002076409504100105 10.1002/ana.25910 10.3390/s19214671 10.5114/aoms/156477 10.3389/fnagi.2023.1200671 10.3390/s21217424 10.1016/j.ajcnut.2023.01.015 10.1038/s41398-018-0150-6 10.3390/s23031279 10.3390/genes11080888 10.1093/nar/gkac830 10.1007/s40336-022-00487-8 10.1111/pcn.13561 10.2196/12910 10.1001/jama.1982.03320430047030 10.3389/fpubh.2023.1100960 10.1016/j.jagp.2015.12.005 10.1093/eurheartj/ehz849 10.1016/B978-012369440-9/50024-4 10.1038/s41588-018-0311-9 10.1212/WNL.47.1.254 10.1001/archneur.64.12.1743 10.1038/s41598-024-64296-x 10.1016/j.toxrep.2024.101756 10.1097/YCO.0000000000000768 10.1186/s13195-022-01140-2 10.1016/S2589-7500(21)00249-1 10.1186/s12883-021-02276-8 |
ContentType | Journal Article |
Copyright | 2024. The Author(s). COPYRIGHT 2024 BioMed Central Ltd. The Author(s) 2024 2024 |
Copyright_xml | – notice: 2024. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: The Author(s) 2024 2024 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.1186/s13195-024-01663-w |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1758-9193 |
EndPage | 17 |
ExternalDocumentID | oai_doaj_org_article_d767a1cd89324de5b1ea87220286f742 PMC11684124 A821889819 39736679 10_1186_s13195_024_01663_w |
Genre | Journal Article |
GeographicLocations | United Kingdom China |
GeographicLocations_xml | – name: United Kingdom – name: China |
GrantInformation_xml | – fundername: Guangdong Provincial Key Laboratory of Traditional Chinese Medicine Informatization grantid: 2021B1212040007 – fundername: Special Projects for Scientific and Technological Research in Chinese Medicine and Ethnomedicine grantid: QZYY-2024-035 |
GroupedDBID | --- 0R~ 23M 2WC 53G 5VS 6J9 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFS ACIHN ACJQM ACUHS ADBBV ADUKV AEAQA AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION DIK E3Z EBD EBLON EBS ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HZ~ IAO IEA IHR IHW INH INR ITC KQ8 M1P M~E O5R O5S O9- OK1 P2P P6G PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ ROL RPM RSV SBL SOJ TR2 TUS UKHRP -56 -5G -BR 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM PMFND 7X8 PJZUB PPXIY 5PM PUEGO |
ID | FETCH-LOGICAL-c518t-f282c4b16bfab1f289866ceea5d96b1d9aae56e1c2398e834c3ae218c781f6da3 |
IEDL.DBID | DOA |
ISSN | 1758-9193 |
IngestDate | Wed Aug 27 01:28:03 EDT 2025 Thu Aug 21 18:34:47 EDT 2025 Tue Aug 05 11:11:53 EDT 2025 Tue Jun 17 21:58:19 EDT 2025 Tue Jun 10 20:58:40 EDT 2025 Thu May 22 21:23:36 EDT 2025 Sun Jan 05 01:57:30 EST 2025 Tue Jul 01 02:38:56 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Risk prediction model Survival analysis DeepSurv Dementia |
Language | English |
License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c518t-f282c4b16bfab1f289866ceea5d96b1d9aae56e1c2398e834c3ae218c781f6da3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doaj.org/article/d767a1cd89324de5b1ea87220286f742 |
PMID | 39736679 |
PQID | 3150344213 |
PQPubID | 23479 |
PageCount | 17 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_d767a1cd89324de5b1ea87220286f742 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11684124 proquest_miscellaneous_3150344213 gale_infotracmisc_A821889819 gale_infotracacademiconefile_A821889819 gale_healthsolutions_A821889819 pubmed_primary_39736679 crossref_primary_10_1186_s13195_024_01663_w |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-12-30 |
PublicationDateYYYYMMDD | 2024-12-30 |
PublicationDate_xml | – month: 12 year: 2024 text: 2024-12-30 day: 30 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Alzheimer's research & therapy |
PublicationTitleAlternate | Alzheimers Res Ther |
PublicationYear | 2024 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | 1663_CR32 SD Edland (1663_CR52) 1996; 47 TP Nguyen (1663_CR30) 2022; 2022 NS Rost (1663_CR59) 2022; 130 LE Trigg (1663_CR35) 2023; 13 HY Sayed (1663_CR40) 2024; 13 H Chen (1663_CR51) 2023; 117 W Li (1663_CR11) 2023; 19 A Sharma (1663_CR20) 2021; 16 H Haider (1663_CR34) 2020; 21 A Rozet (1663_CR27) 2019; 21 Y Lin (1663_CR47) 2020; 11 RE Marioni (1663_CR16) 2018; 8 C Sudlow (1663_CR14) 2015; 12 X Heng (1663_CR2) 2023; 11 P Sanga (1663_CR28) 2023; 13 IA Kang (1663_CR25) 2023; 10 S Tsuzuki (1663_CR36) 2020; 10 DJ Oh (1663_CR54) 2023; 77 KM Park (1663_CR8) 2019; 14 T Ninomiya (1663_CR57) 2014; 14 G Kaur (1663_CR45) 2022; 10 C Prasanna (1663_CR23) 2023; 23 W Xu (1663_CR49) 2015; 86 X Shang (1663_CR55) 2023; 15 1663_CR41 TG Fong (1663_CR1) 2022; 18 Y Minami (1663_CR60) 1995; 41 A Merkin (1663_CR10) 2022; 35 Q Zhou (1663_CR37) 2021; 12 SJ Jiao (1663_CR31) 2021; 21 Z Raisi-Estabragh (1663_CR15) 2020; 116 IE Jansen (1663_CR17) 2019; 51 Y Liu (1663_CR26) 2024; 14 JB Chen (1663_CR44) 2021; 12 SA Lambert (1663_CR50) 2019; 28 J Steinfeldt (1663_CR13) 2022; 4 FJ Harrell (1663_CR33) 1982; 247 M Salwa (1663_CR38) 2024; 8 W Yang (1663_CR29) 2019; 19 C Surianarayanan (1663_CR46) 2023; 23 KM Langa (1663_CR4) 2017; 177 JL Katzman (1663_CR12) 2018; 18 L Wang (1663_CR9) 2021; 21 E Gomez-Tortosa (1663_CR53) 2007; 64 JJ Zhang (1663_CR56) 2023; 15 1663_CR21 NA Kochan (1663_CR62) 2016; 24 YT Wu (1663_CR5) 2016; 15 Y Leng (1663_CR18) 2021; 89 C Cooper (1663_CR61) 2017; 46 X Zou (1663_CR39) 2024; 24 J Feng (1663_CR43) 2021; 22 M Fan (1663_CR19) 2020; 41 K Walters (1663_CR7) 2016; 14 A Fayosse (1663_CR48) 2020; 18 S Chatterjee (1663_CR58) 2016; 39 A Bashiri (1663_CR42) 2017; 46 D Huang (1663_CR24) 2022; 50 M Tao (1663_CR6) 2023; 13 A Page (1663_CR3) 2015; 5 Q Wang (1663_CR22) 2024; 15 |
References_xml | – volume: 12 year: 2015 ident: 1663_CR14 publication-title: PLOS Med doi: 10.1371/journal.pmed.1001779 – volume: 14 start-page: e0211957 year: 2019 ident: 1663_CR8 publication-title: PLoS One. doi: 10.1371/journal.pone.0211957 – volume: 16 start-page: e0251365 year: 2021 ident: 1663_CR20 publication-title: PLoS One. doi: 10.1371/journal.pone.0251365 – volume: 13 start-page: 737 year: 2023 ident: 1663_CR6 publication-title: Behav Sci (Basel). doi: 10.3390/bs13090737 – volume: 177 start-page: 51 year: 2017 ident: 1663_CR4 publication-title: JAMA Intern Med doi: 10.1001/jamainternmed.2016.6807 – volume: 28 start-page: R133 year: 2019 ident: 1663_CR50 publication-title: HUM MOL GENET doi: 10.1093/hmg/ddz187 – volume: 15 start-page: 1410396 year: 2024 ident: 1663_CR22 publication-title: FRONT PSYCHOL doi: 10.3389/fpsyg.2024.1410396 – ident: 1663_CR32 – volume: 13 start-page: 3063 year: 2023 ident: 1663_CR35 publication-title: SCI REP-UK doi: 10.1038/s41598-023-27892-x – volume: 10 start-page: 245 year: 2023 ident: 1663_CR25 publication-title: Bioengineering (Basel). doi: 10.3390/bioengineering10020245 – volume: 24 start-page: 153 year: 2024 ident: 1663_CR39 publication-title: BMC PULM MED doi: 10.1186/s12890-024-02945-7 – volume: 15 start-page: 116 year: 2016 ident: 1663_CR5 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(15)00092-7 – volume: 116 start-page: e12 year: 2020 ident: 1663_CR15 publication-title: Cardiovasc Res doi: 10.1093/cvr/cvz294 – volume: 46 start-page: 393 year: 2017 ident: 1663_CR61 publication-title: AGE AGEING doi: 10.1093/ageing/afx044 – volume: 14 start-page: 6 year: 2016 ident: 1663_CR7 publication-title: BMC Med doi: 10.1186/s12916-016-0549-y – volume: 18 start-page: 24 year: 2018 ident: 1663_CR12 publication-title: BMC Med Res Methodol doi: 10.1186/s12874-018-0482-1 – volume: 22 start-page: 47 year: 2021 ident: 1663_CR43 publication-title: BMC Bioinformatics doi: 10.1186/s12859-020-03850-6 – volume: 5 start-page: e008048 year: 2015 ident: 1663_CR3 publication-title: BMJ Open doi: 10.1136/bmjopen-2015-008048 – volume: 130 start-page: 1252 year: 2022 ident: 1663_CR59 publication-title: CIRC RES doi: 10.1161/CIRCRESAHA.122.319951 – volume: 18 start-page: 579 year: 2022 ident: 1663_CR1 publication-title: Nat Rev Neurol. doi: 10.1038/s41582-022-00698-7 – volume: 23 start-page: 7712 year: 2023 ident: 1663_CR23 publication-title: Sensors (Basel). doi: 10.3390/s23187712 – volume: 10 start-page: 3502 year: 2020 ident: 1663_CR36 publication-title: SCI REP-UK doi: 10.1038/s41598-020-60444-1 – volume: 14 start-page: 487 year: 2014 ident: 1663_CR57 publication-title: CURR DIABETES REP doi: 10.1007/s11892-014-0487-z – volume: 12 start-page: 1755284400 year: 2021 ident: 1663_CR44 publication-title: THER ADV CHRONIC DIS doi: 10.1177/2040622321992624 – volume: 39 start-page: 300 year: 2016 ident: 1663_CR58 publication-title: Diabetes Care. doi: 10.2337/dc15-1588 – volume: 12 start-page: 749854 year: 2021 ident: 1663_CR37 publication-title: Front Plant Sci. doi: 10.3389/fpls.2021.749854 – volume: 21 start-page: 1 year: 2020 ident: 1663_CR34 publication-title: J Mach Learn Res. – volume: 13 start-page: 3159 year: 2023 ident: 1663_CR28 publication-title: Diagnostics. doi: 10.3390/diagnostics13193159 – volume: 18 start-page: 107 year: 2020 ident: 1663_CR48 publication-title: BMC MED doi: 10.1186/s12916-020-01578-x – volume: 46 start-page: 165 year: 2017 ident: 1663_CR42 publication-title: IRAN J PUBLIC HEALTH – volume: 41 start-page: 47 year: 1995 ident: 1663_CR60 publication-title: INT J SOC PSYCHIATR doi: 10.1177/002076409504100105 – volume: 89 start-page: 177 year: 2021 ident: 1663_CR18 publication-title: ANN NEUROL doi: 10.1002/ana.25910 – volume: 19 start-page: 4671 year: 2019 ident: 1663_CR29 publication-title: Sensors (Basel). doi: 10.3390/s19214671 – volume: 19 start-page: 264 year: 2023 ident: 1663_CR11 publication-title: ARCH Med Sci doi: 10.5114/aoms/156477 – volume: 15 start-page: 1200671 year: 2023 ident: 1663_CR56 publication-title: FRONT AGING NEUROSCI doi: 10.3389/fnagi.2023.1200671 – volume: 21 start-page: 7424 year: 2021 ident: 1663_CR31 publication-title: Sensors (Basel). doi: 10.3390/s21217424 – volume: 117 start-page: 672 year: 2023 ident: 1663_CR51 publication-title: AM J CLIN NUTR doi: 10.1016/j.ajcnut.2023.01.015 – ident: 1663_CR21 – volume: 8 start-page: 99 year: 2018 ident: 1663_CR16 publication-title: Transl Psychiat doi: 10.1038/s41398-018-0150-6 – volume: 23 start-page: 1279 year: 2023 ident: 1663_CR46 publication-title: Sensors (Basel). doi: 10.3390/s23031279 – volume: 11 start-page: 888 year: 2020 ident: 1663_CR47 publication-title: Genes (Basel). doi: 10.3390/genes11080888 – volume: 50 start-page: 10290 year: 2022 ident: 1663_CR24 publication-title: NUCLEIC ACIDS RES doi: 10.1093/nar/gkac830 – volume: 10 start-page: 355 year: 2022 ident: 1663_CR45 publication-title: CLIN TRANSL IMAGING doi: 10.1007/s40336-022-00487-8 – volume: 77 start-page: 449 year: 2023 ident: 1663_CR54 publication-title: PSYCHIAT CLIN NEUROS doi: 10.1111/pcn.13561 – volume: 21 start-page: e12910 year: 2019 ident: 1663_CR27 publication-title: J Med Internet Res. doi: 10.2196/12910 – volume: 247 start-page: 2543 year: 1982 ident: 1663_CR33 publication-title: JAMA doi: 10.1001/jama.1982.03320430047030 – volume: 11 start-page: 1100960 year: 2023 ident: 1663_CR2 publication-title: China Front Public Health doi: 10.3389/fpubh.2023.1100960 – volume: 24 start-page: 221 year: 2016 ident: 1663_CR62 publication-title: AM J GERIAT PSYCHIAT doi: 10.1016/j.jagp.2015.12.005 – volume: 41 start-page: 1182 year: 2020 ident: 1663_CR19 publication-title: EUR HEART J doi: 10.1093/eurheartj/ehz849 – ident: 1663_CR41 doi: 10.1016/B978-012369440-9/50024-4 – volume: 51 start-page: 404 year: 2019 ident: 1663_CR17 publication-title: Nat Genet doi: 10.1038/s41588-018-0311-9 – volume: 47 start-page: 254 year: 1996 ident: 1663_CR52 publication-title: Neurology doi: 10.1212/WNL.47.1.254 – volume: 64 start-page: 1743 year: 2007 ident: 1663_CR53 publication-title: Arch Neurol. doi: 10.1001/archneur.64.12.1743 – volume: 14 start-page: 13747 year: 2024 ident: 1663_CR26 publication-title: SCI REP-UK doi: 10.1038/s41598-024-64296-x – volume: 8 start-page: e12 year: 2024 ident: 1663_CR38 publication-title: Health Lit Res Pract – volume: 13 year: 2024 ident: 1663_CR40 publication-title: Toxicol Rep doi: 10.1016/j.toxrep.2024.101756 – volume: 35 start-page: 123 year: 2022 ident: 1663_CR10 publication-title: Curr Opin Psychiatr doi: 10.1097/YCO.0000000000000768 – volume: 2022 start-page: 6379141 year: 2022 ident: 1663_CR30 publication-title: COMPUT INTEL NEUROSC – volume: 86 start-page: 1299 year: 2015 ident: 1663_CR49 publication-title: J NEUROL NEUROSUR PS – volume: 15 start-page: 7 year: 2023 ident: 1663_CR55 publication-title: ALZHEIMERS RES THER doi: 10.1186/s13195-022-01140-2 – volume: 4 start-page: e84 year: 2022 ident: 1663_CR13 publication-title: Lancet Digit Health doi: 10.1016/S2589-7500(21)00249-1 – volume: 21 start-page: 271 year: 2021 ident: 1663_CR9 publication-title: BMC Neurol. doi: 10.1186/s12883-021-02276-8 |
SSID | ssj0066284 |
Score | 2.3578577 |
Snippet | Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or treatment are of... Background Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or treatment... Abstract Background Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 278 |
SubjectTerms | Aged Deep Learning DeepSurv Dementia Dementia - epidemiology Dementia - genetics Environmental aspects Female Genetic aspects Humans Machine learning Male Middle Aged Proportional Hazards Models Prospective Studies Risk Assessment - methods Risk Factors Risk prediction model Survival Analysis United Kingdom - epidemiology |
Title | Development of an individualized dementia risk prediction model using deep learning survival analysis incorporating genetic and environmental factors |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39736679 https://www.proquest.com/docview/3150344213 https://pubmed.ncbi.nlm.nih.gov/PMC11684124 https://doaj.org/article/d767a1cd89324de5b1ea87220286f742 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5BuXBBIF6GEhYJiQOy2vU-fWyjVhUSFUJUym213kfJxYmaRJX4H_xfZnadyBYHLhydHVuendeOM_MNIR_ByJKSmtWJeVkL7mPdStDlJL1nyQiePH7v-Hqtrm7El4VcjEZ9YU1YgQcuG3cStNKO-QBxtREhyo5FZ3QDObtRCfI69L4Q8_bJVPHBSoHX3bfIGHWyYZzlTmSsuIAYW99PwlBG6__bJ4-C0rRgchSBLp-SJ8PRkZ6VV35GHsT-Ofk9qvqhq0RdT5eHHqvlrxhoyB8Al45iFTld3-E_MygNmofgUCx8vwWiuKbDBIlbutmBAwEVhKcVyBKKGA4F8hjXQemw9xGWAx11ysENw_ieF-Tm8uLH_KoeRi3UXjKzrRNkXl50THXJdQyuWqMUxE8nQ6s6FlrnolSReYQLjIYLz12E04HXhiUVHH9JjvpVH18TKpUJruEpGBFESKFN2nkmpDl1zDnpKvJ5v_N2XRA1bM5EjLJFThbkZLOc7H1FzlE4B0pEw84_gI7YQUfsv3SkIu9RtLa0lh5s2p4ZYAFYZW1FPmUKtGqQsHdDcwKwhPhYE8rjCSVYo58sf9irj8UlLGHr42q3sRyO3lyIhvGKvCrqdOAKDoVcKQ13m4miTdiervTLnxkMnDFlcIL4m_-xUW_J4waNBIEsT4_J0fZuF9_BoWvbzchDvdAz8uj84vrbd7iaq_ks29wf4MExng |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+of+an+individualized+dementia+risk+prediction+model+using+deep+learning+survival+analysis+incorporating+genetic+and+environmental+factors&rft.jtitle=Alzheimer%27s+research+%26+therapy&rft.au=Yuan%2C+Shiqi&rft.au=Liu%2C+Qing&rft.au=Huang%2C+Xiaxuan&rft.au=Tan%2C+Shanyuan&rft.date=2024-12-30&rft.pub=BioMed+Central+Ltd&rft.issn=1758-9193&rft.eissn=1758-9193&rft.volume=16&rft.issue=1&rft_id=info:doi/10.1186%2Fs13195-024-01663-w&rft.externalDocID=A821889819 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1758-9193&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1758-9193&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1758-9193&client=summon |